Xavier F Castellanos

7PUBLICATIONS
39CO-AUTHORS
Deep learningChild and adolescent developmentGene expression (incl. microarray and other genome-wide approaches)Medicinal and biomolecular chemistry not elsewhere classifiedTesting, assessment and psychometrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2026
Deep Learning for AD Risk Screening and Progression Prediction.

|May 28, 2026
A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability.

|Oct 23, 2025
Connectome-based symptom mapping and in silico related gene expression in children with autism and/or attention-deficit/hyperactivity disorder.

Patricia Segura, Marco Pagani, Somer L Bishop

|Apr 18, 2025
Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Oral Cannabidiol and Tetrahydrocannabinol for Essential Tremor.

Katherine Longardner, Qian Shen, Francisco X Castellanos

|Jan 31, 2019
ADGRL3 (LPHN3) variants predict substance use disorder.

Mauricio Arcos-Burgos, Jorge I Vélez, Ariel F Martinez

|Mar 15, 2017
Enhancing studies of the connectome in autism using the autism brain imaging data exchange II.

Adriana Di Martino, David O'Connor, Bosi Chen

Pageof 2

Frequent Collaborators

1 joint publications

Ali M Golestani

1 joint publications

Mariana Lazar

1 joint publications

Joshua H Balsters

1 joint publications

Sylvie Bernaerts